Lifevantage CorpLFVN
Price$6.24Intrinsic value$4.8922% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $182.6M-20.1% YoYTTM through 31 Mar 2026
Net Income $5.1M-48.3% YoYTTM through 31 Mar 2026
Free Cash Flow $6.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin79.0%
EBITDA Margin4.9%
Operating Margin3.8%
Net Margin2.8%

Returns

15.1%ROE
8.2%ROA
37.9%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.90x
Net Debt-$12.5Mnet cash position
Cash & Equivalents$20.2M

Quality Metrics

Altman Z-Score2.93
Piotroski F-Score4 / 9
FCF Margin3.7%
Rule of 404.5
Earnings-Beat Rate0.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $182.6M
Diluted EPS$0.40TTM
'20'21'22'23'24'25'26
FY2026: $0.40

Dividend

$0.10Per share, FY20263.50%Yield

Capital Allocation

R&D Spend$1M
Capex Intensity2.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.